Corcept Therapeutics Inc

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP CORT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

149,845

Value ($000)

5,215

Weight

0.0%

2019 Q4 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	5,215	0.0%	149,845	12/31/2025
2025 Q3	11/13/2025	30,700	0.0%	369,388	9/30/2025
2025 Q2	8/13/2025	57,899	0.0%	788,809	6/30/2025
2025 Q1	5/14/2025	170,442	0.1%	1,492,227	3/31/2025
2024 Q4	2/12/2025	82,889	0.1%	1,644,942	12/31/2024
2024 Q3	11/14/2024	73,151	0.1%	1,580,621	9/30/2024
2024 Q2	8/14/2024	48,196	0.0%	1,483,422	6/30/2024
2024 Q1	5/15/2024	42,487	0.0%	1,686,671	3/31/2024
2023 Q4	2/14/2024	35,764	0.0%	1,101,103	12/31/2023
2023 Q3	11/14/2023	30,119	0.0%	1,105,469	9/30/2023
2023 Q2	8/14/2023	6,301	0.0%	283,190	6/30/2023
2023 Q1	5/15/2023	219	0.0%	10,093	3/31/2023
2022 Q4	2/14/2023	468	0.0%	23,048	12/31/2022
2022 Q1	5/13/2022	318	0.0%	14,142	3/31/2022
2021 Q4	2/14/2022	9,725	0.0%	491,162	12/31/2021
2021 Q3	11/12/2021	29,314	0.0%	1,489,544	9/30/2021
2021 Q2	8/13/2021	13,991	0.0%	635,968	6/30/2021
2021 Q1	5/14/2021	24,914	0.0%	1,047,263	3/31/2021
2020 Q4	2/12/2021	26,786	0.0%	1,023,936	12/31/2020
2020 Q3	11/12/2020	16,350	0.0%	939,408	9/30/2020
2020 Q2	8/12/2020	15,659	0.0%	930,953	6/30/2020
2020 Q1	5/15/2020	14,098	0.0%	1,185,737	3/31/2020
2019 Q4	2/13/2020	17,093	0.0%	1,412,627	12/31/2019